The dilemma of the prolonged QT interval in early drug studies
- 1 February 1996
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 41 (2), 77-81
- https://doi.org/10.1111/j.1365-2125.1996.tb00163.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Drug-Induced Torsade de PointesDrug Safety, 1994
- Mechanisms of cardiac arrhythmiasThe Lancet, 1993
- Cardiotoxic effects of astemizole overdose in childrenThe Journal of Pediatrics, 1992
- Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmiaThe American Journal of Cardiology, 1991
- Acute electrophysiologic effects of an HT2-serotonin antagonist, ketanserin, in humansCardiovascular Drugs and Therapy, 1990
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- Correction of the QT interval for heart rate: Review of different formulas and the use of Bazett's formula in myocardial infarctionAmerican Heart Journal, 1985
- Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.Circulation, 1981
- Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden deathAmerican Heart Journal, 1957
- The Measurement of the Q-T Interval of the ElectrocardiogramCirculation, 1952